^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ARC-02

i
Other names: ARC-02
News
Trials
Company:
Araris Biotech
Drug class:
Microtubule inhibitor, CD79b-targeted antibody-drug conjugate
Related drugs:
News
Trials